Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis

This clinical trial compares a paclitaxel-coated balloon vs an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary interventi

Related Keywords

United States ,Germany ,Washington ,Helsinki ,Eteläuomen Läi ,Finland ,Boston ,Massachusetts ,German ,Asahi Intecc ,Edwards Lifesciences ,Robertw Yeh ,Drug Administration ,Institute Inc ,Meeting Of Cardiovascular Research Technologies ,Baim Institute For Clinical Research Inc ,Blood Institute ,Columbia University ,Society For Cardiovascular Angiography ,Cardiovascular Research Foundation ,Amgen ,Medtronic ,Novartis ,Boston Scientific ,Abiomed ,Outcomes Research ,Boston Scientific Corp ,Beth Israel Deaconess Medical Center ,Academic Research Consortium ,Philips ,Group Information ,Susan Smith Center ,National Heart ,Clinical Trial ,Agent Paclitaxel Coated ,Subjects With In Stent Restenosis ,Cardiovascular Angiography ,End Point ,Subgroup Analyses ,Breakthrough Device ,Fourth Floor ,Drs Yeh ,Interest Disclosures ,Abbott Vascular ,Elixir Medical ,Shockwave Medical ,Orchestra Biomed ,Concept Medical ,Cardiovascular Research ,Recor Medical ,Bolt Medical ,Magenta Medical ,Baim Institute ,Clinical Research Inc ,Cardiovascular Research Technologies ,